Biofilm models of polymicrobial infection

Future Microbiology

Volumn 10, Issue 12, 2015, Pages 1997-2015

  Gabrilska, Rebecca A ^a   Rumbaugh, Kendra P ^a  

^a TEXAS TECH UNIVERSITY   (United States)

Author keywords

antagonism; biofilm; in vitro model; in vivo model; polymicrobial; synergy

Indexed keywords

ANTIBIOSIS; BIOFILM; CAENORHABDITIS ELEGANS; CLOSTRIDIUM PERFRINGENS; COCULTURE; COMMUNITY STRUCTURE; DISEASE COURSE; DROSOPHILA MELANOGASTER; FLAVOBACTERIUM; IN VITRO STUDY; IN VIVO STUDY; INFECTION; KLEBSIELLA PNEUMONIAE; LACTOBACILLUS CASEI; LUNG INFECTION; MICROCOSM; MICROFLUIDICS; MICROTITER PLATE ASSAY; MOUTH FLORA; NATURAL HOST; NONHUMAN; POLYMICROBIAL INFECTION; PRIORITY JOURNAL; REVIEW; SKIN INFECTION; SOFT TISSUE INFECTION; SPECIES COMPOSITION; STAPHYLOCOCCUS EPIDERMIDIS; URINARY TRACT INFECTION; WOUND INFECTION; ANIMAL; BIOLOGICAL MODEL; GROWTH, DEVELOPMENT AND AGING; HUMAN; MICROBIAL CONSORTIUM; MICROBIOLOGY; MIXED INFECTION; ORGANISMAL INTERACTION;

ANIMALS; BIOFILMS; COINFECTION; HUMANS; MICROBIAL CONSORTIA; MICROBIAL INTERACTIONS; MODELS, BIOLOGICAL;

EID: 84948419468     PISSN: 17460913     EISSN: 17460921     Source Type: Journal    
DOI: 10.2217/fmb.15.109     Document Type: Review

References (118)

1. Peters BM, Jabra-Rizk MA, O'May GA, Costerton JW, Shirtliff ME. Polymicrobial interactions: impact on pathogenesis and human disease. Clin. Microbiol. Rev. 25(1), 193-213 (2012).
2. Coenye T, Nelis HJ. In vitro and in vivo model systems to study microbial biofilm formation. J. Microbiol. Methods 83(2), 89-105 (2010).
3. Lebeaux D, Chauhan A, Rendueles O, Beloin C. From in vitro to in vivo models of bacterial biofilm-related infections. Pathogens 2(2), 288-356 (2013).
4. Bakaletz LO. Developing animal models for polymicrobial diseases. Nat. Rev. Microbiol. 2(7), 552-568 (2004).
5. Chandra J, Pearlman E, Ghannoum MA. Animal models to investigate fungal biofilm formation. Methods Mol. Biol. 1147, 141-157 (2014).
6. Mclean RJ, Kakirde KS. Enhancing metagenomics investigations of microbial interactions with biofilm technology. Int. J. Mol. Sci. 14(11), 22246-22257 (2013).
7. Murray JL, Connell JL, Stacy A, Turner KH, Whiteley M. Mechanisms of synergy in polymicrobial infections. J. Microbiol. 52(3), 188-199 (2014).
8. Romling U, Balsalobre C. Biofilm infections, their resilience to therapy and innovative treatment strategies. J. Intern. Med. 272(6), 541-561 (2012).
9. Burmolle M, Ren D, Bjarnsholt T, Sorensen SJ. Interactions in multispecies biofilms: do they actually matter Trends Microbiol. 22(2), 84-91 (2014).
10. Elias S, Banin E. Multi-species biofilms: living with friendly neighbors. FEMS Microbiol. Rev. 36(5), 990-1004 (2012).
11. Wolcott R, Costerton JW, Raoult D, Cutler SJ. The polymicrobial nature of biofilm infection. Clin. Microbiol. Infect. 19(2), 107-112 (2013).
12. Ehrlich GD, Hu FZ, Shen K, Stoodley P, Post JC. Bacterial plurality as a general mechanism driving persistence in chronic infections. Clin. Orthop. Relat. Res. (437), 20-24 (2005).
13. Moons P, Michiels CW, Aertsen A. Bacterial interactions in biofilms. Crit. Rev. Microbiol. 35(3), 157-168 (2009).
14. Short FL, Murdoch SL, Ryan RP. Polybacterial human disease: the ills of social networking. Trends Microbiol. 22(9), 508-516 (2014).
15. Rendueles O, Ghigo JM. Multi-species biofilms: how to avoid unfriendly neighbors. FEMS Microbiol. Rev. 36(5), 972-989 (2012).
16. Bjornson HS, Colley R, Bower RH, Duty VP, Schwartz-Fulton JT, Fischer JE. Association between microorganism growth at the catheter insertion site and colonization of the catheter in patients receiving total parenteral nutrition. Surgery 92(4), 720-727 (1982).
17. Chen PB, Davern LB, Katz J, Eldridge JH, Michalek SM. Host responses induced by co-infection with Porphyromonas gingivalis and Actinobacillus actinomycetemcomitans in a murine model. Oral Microbiol. Immunol. 11(4), 274-281 (1996).
18. Kesavalu L, Holt SC, Ebersole JL. Virulence of a polymicrobic complex, treponema denticola and Porphyromonas gingivalis in a murine model. Oral Microbiol. Immunol. 13(6), 373-377 (1998).
19. Nagashima H, Takao A, Maeda N. Abscess forming ability of streptococcus milleri group: synergistic effect with Fusobacterium nucleatum. Microbiol. Immunol. 43(3), 207-216 (1999).
20. Hendricks KJ, Burd TA, Anglen JO, Simpson AW, Christensen GD, Gainor BJ. Synergy between Staphylococcus aureus and Pseudomonas aeruginosa in a rat model of complex orthopaedic wounds. J. Bone Joint Surg. Am. 83-A(6), 855-861 (2001).
21. Ramos C, Licht TR, Sternberg C, Krogfelt KA, Molin S. Monitoring bacterial growth activity in biofilms from laboratory flow chambers, plant rhizosphere, and animal intestine. Methods Enzymol. 337, 21-42 (2001).
22. Mastropaolo MD, Evans NP, Byrnes MK, Stevens AM, Robertson JL, Melville SB. Synergy in polymicrobial infections in a mouse model of Type 2 diabetes. Infect. Immun. 73(9), 6055-6063 (2005).
23. Burmolle M, Webb JS, Rao D, Hansen LH, Sorensen SJ, Kjelleberg S. Enhanced biofilm formation and increased resistance to antimicrobial agents and bacterial invasion are caused by synergistic interactions in multispecies biofilms. Appl. Environ. Microbiol. 72(6), 3916-3923 (2006).
24. Harriott MM, Noverr MC. Candida albicans and Staphylococcus aureus form polymicrobial biofilms: effects on antimicrobial resistance. Antimicrob. Agents Chemother. 53(9), 3914-3922 (2009).
25. Dalton T, Dowd SE, Wolcott RD et al. An in vivo polymicrobial biofilm wound infection model to study interspecies interactions. PLoS ONE 6(11), e27317 (2011).
26. Deleon S, Clinton A, Fowler H, Everett J, Horswill AR, Rumbaugh KP. Synergistic interactions of Pseudomonas aeruginosa and Staphylococcus aureus in an in vitro wound model. Infect. Immun. 82(11), 4718-4728 (2014).
27. Perez AC, Pang B, King LB et al. Residence of Streptococcus pneumoniae and Moraxella catarrhalis within polymicrobial biofilm promotes antibiotic resistance and bacterial persistence in vivo. Pathog. Dis. 70(3), 280-288 (2014).
28. Liao YT, Kuo SC, Lee YT et al. Sheltering effect and indirect pathogenesis of carbapenem-resistant Acinetobacter baumannii in polymicrobial infection. Antimicrob. Agents Chemother. 58(7), 3983-3990 (2014).
29. Ramsey MM, Rumbaugh KP, Whiteley M. Metabolite cross-feeding enhances virulence in a model polymicrobial infection. PLoS Pathog. 7(3), e1002012 (2011).
30. Samaranayake YH, Bandara HM, Cheung BP, Yau JY, Yeung SK, Samaranayake LP. Enteric Gram-negative bacilli suppress Candida biofilms on foley urinary catheters. APMIS 122(1), 47-58 (2014).
31. Cruz MR, Graham CE, Gagliano BC, Lorenz MC, Garsin DA. Enterococcus faecalis inhibits hyphal morphogenesis and virulence of Candida albicans. Infect. Immun. 81(1), 189-200 (2013).
32. Peleg AY, Tampakakis E, Fuchs BB, Eliopoulos GM, Moellering RC Jr., Mylonakis E. Prokaryote-eukaryote interactions identified by using Caenorhabditis elegans. Proc. Natl Acad. Sci. USA 105(38), 14585-14590 (2008).
33. Tampakakis E, Peleg AY, Mylonakis E. Interaction of Candida albicans with an intestinal pathogen, salmonella enterica serovar typhimurium. Eukaryot. Cell 8(5), 732-737 (2009).
34. Liao KS, Lehman SM, Tweardy DJ, Donlan RM, Trautner BW. Bacteriophages are synergistic with bacterial interference for the prevention of Pseudomonas aeruginosa biofilm formation on urinary catheters. J. Appl. Microbiol. 113(6), 1530-1539 (2012).
35. Curtin JJ, Donlan RM. Using bacteriophages to reduce formation of catheter-associated biofilms by Staphylococcus epidermidis. Antimicrob. Agents Chemother. 50(4), 1268-1275 (2006).
36. Lee KW, Periasamy S, Mukherjee M, Xie C, Kjelleberg S, Rice SA. Biofilm development and enhanced stress resistance of a model, mixed-species community biofilm. ISME J 8(4), 894-907 (2014).
37. Zhang W, Sileika T, Packman AI. Effects of fluid flow conditions on interactions between species in biofilms. FEMS Microbiol. Ecol. 84(2), 344-354 (2013).
38. Wright E, Neethirajan S, Weng X. Microfluidic wound model for studying the behaviours of Pseudomonas aeruginosa in polymicrobial biofilms. Biotechnol. Bioeng. 112(11), 2351-2359 (2015).
39. Ventolini G, Mitchell E, Salazar M. Biofilm formation by vaginal lactobacillus in vivo. Med. Hypotheses 84(5), 417-420 (2015).
40. Rieu A, Aoudia N, Jego G et al. The biofilm mode of life boosts the anti-inflammatory properties of lactobacillus. Cell Microbiol. 16(12), 1836-1853 (2014).
41. Peeters E, Nelis HJ, Coenye T. Comparison of multiple methods for quantification of microbial biofilms grown in microtiter plates. J. Microbiol. Methods 72(2), 157-165 (2008).
42. Zhu Y, Dashper SG, Chen YY, Crawford S, Slakeski N, Reynolds EC. Porphyromonas gingivalis and treponema denticola synergistic polymicrobial biofilm development. PLoS ONE 8(8), e71727 (2013).
43. Ceri H, Olson ME, Stremick C, Read RR, Morck D, Buret A. The calgary biofilm device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J. Clin. Microbiol. 37(6), 1771-1776 (1999).
44. Olson ME, Ceri H, Morck DW, Buret AG, Read RR. Biofilm bacteria: Formation and comparative susceptibility to antibiotics. Can. J. Vet Res. 66(2), 86-92 (2002).
45. Costa AC, Pereira CA, Freire F, Junqueira JC, Jorge AO. Methods for obtaining reliable and reproducible results in studies of Candida biofilms formed in vitro. Mycoses 56(6), 614-622 (2013).
46. Karched M, Bhardwaj RG, Inbamani A, Asikainen S. Quantitation of biofilm and planktonic life forms of coexisting periodontal species. Anaerobe 35(Pt A), 13-20 (2015).
47. Soares GM, Teles F, Starr JR et al. Effects of azithromycin, metronidazole, amoxicillin, and metronidazole plus amoxicillin on an in vitro polymicrobial subgingival biofilm model. Antimicrob. Agents Chemother. 59(5), 2791-2798 (2015).
48. Manavathu EK, Vager DL, Vazquez JA. Development and antimicrobial susceptibility studies of in vitro monomicrobial and polymicrobial biofilm models with aspergillus fumigatus and Pseudomonas aeruginosa. BMC Microbiol. 14, 53 (2014).
49. Harriott MM, Noverr MC. Ability of Candida albicans mutants to induce Staphylococcus aureus vancomycin resistance during polymicrobial biofilm formation. Antimicrob. Agents Chemother. 54(9), 3746-3755 (2010).
50. De Brucker K, Tan Y, Vints K et al. Fungal beta-1,3-glucan increases ofloxacin tolerance of Escherichia coli in a polymicrobial E. coli/Candida albicans biofilm. Antimicrob. Agents Chemother. 59(6), 3052-3058 (2015).
51. Crusz SA, Popat R, Rybtke MT et al. Bursting the bubble on bacterial biofilms: a flow cell methodology. Biofouling 28(8), 835-842 (2012).
52. Weiss Nielsen M, Sternberg C, Molin S, Regenberg B. Pseudomonas aeruginosa and saccharomyces cerevisiae biofilm in flow cells. J. Vis. Exp. 47, (2011).
53. Krajewski S, Rheinlaender J, Ries P et al. Bacterial interactions with proteins and cells relevant to the development of lifethreatening endocarditis studied by use of a quartz-crystal microbalance. Anal. Bioanal. Chem. 406(14), 3395-3406 (2014).
54. Biyikoglu B, Ricker A, Diaz PI. Strain-specific colonization patterns and serum modulation of multi-species oral biofilm development. Anaerobe 18(4), 459-470 (2012).
55. Blanc V, Isabal S, Sanchez MC et al. Characterization and application of a flow system for in vitro multispecies oral biofilm formation. J. Periodontal Res. 49(3), 323-332 (2014).
56. Goeres DM, Hamilton MA, Beck NA et al. A method for growing a biofilm under low shear at the air-liquid interface using the drip flow biofilm reactor. Nat. Protoc. 4(5), 783-788 (2009).
57. Li X, Song JL, Culotti A et al. Methods for characterizing the co-development of biofilm and habitat heterogeneity. J. Vis. Exp. 97, (2015).
58. Kim J, Park HD, Chung S. Microfluidic approaches to bacterial biofilm formation. Molecules 17(8), 9818-9834 (2012).
59. Woods J, Boegli L, Kirker KR et al. Development and application of a polymicrobial, in vitro wound biofilm model. J. Appl. Microbiol. 112(5), 998-1006 (2012).
60. Samarian DS, Jakubovics NS, Luo TL, Rickard AH. Use of a high-throughput in vitro microfluidic system to develop oral multi-species biofilms. J. Vis. Exp. 94, (2014).
61. Kolderman E, Bettampadi D, Samarian D et al. L-arginine destabilizes oral multi-species biofilm communities developed in human saliva. PLoS ONE 10(5), e0121835 (2015).
62. Lundstrom JR, Williamson AE, Villhauer AL, Dawson DV, Drake DR. Bactericidal activity of stabilized chlorine dioxide as an endodontic irrigant in a polymicrobial biofilm tooth model system. J. Endod. 36(11), 1874-1878 (2010).
63. Birkenhauer E, Neethirajan S, Weese JS. Collagen and hyaluronan at wound sites influence early polymicrobial biofilm adhesive events. BMC Microbiol. 14, 191 (2014).
64. Hill KE, Malic S, Mckee R et al. An in vitro model of chronic wound biofilms to test wound dressings and assess antimicrobial susceptibilities. J. Antimicrob. Chemother. 65(6), 1195-1206 (2010).
65. Sun Y, Dowd SE, Smith E, Rhoads DD, Wolcott RD. In vitro multispecies lubbock chronic wound biofilm model. Wound Repair Regen. 16(6), 805-813 (2008).
66. Kucera J, Sojka M, Pavlik V, Szuszkiewicz K, Velebny V, Klein P. Multispecies biofilm in an artificial wound bed-a novel model for in vitro assessment of solid antimicrobial dressings. J. Microbiol. Methods 103, 18-24 (2014).
67. Guggenheim M, Thurnheer T, Gmur R, Giovanoli P, Guggenheim B. Validation of the zurich burn-biofilm model. Burns 37(7), 1125-1133 (2011).
68. Brooks T, Keevil CW. A simple artificial urine for the growth of urinary pathogens. Lett. Appl. Microbiol. 24(3), 203-206 (1997).
69. Williams DH, Schaeffer AJ. Current concepts in urinary tract infections. Minerva Urol. Nefrol. 56(1), 15-31 (2004).
70. Stickler DJ, Morris NS, Winters C. Simple physical model to study formation and physiology of biofilms on urethral catheters. Methods Enzymol. 310, 494-501 (1999).
71. Macleod SM, Stickler DJ. Species interactions in mixed-community crystalline biofilms on urinary catheters. J. Med. Microbiol. 56(Pt 11), 1549-1557 (2007).
72. Mukherjee S, Weimer KE, Seok SC et al. Host-to-host variation of ecological interactions in polymicrobial infections. Phys. Biol. 12(1), 016003 (2014).
73. Edwards S, Kjellerup BV. Exploring the applications of invertebrate host-pathogen models for in vivo biofilm infections. FEMS Immunol. Med. Microbiol. 65(2), 205-214 (2012).
74. Arvanitis M, Fuchs BB, Mylonakis E. Nonmammalian model systems to investigate fungal biofilms. Methods Mol. Biol. 1147, 159-172 (2014).
75. Glavis-Bloom J, Muhammed M, Mylonakis E. Of model hosts and man: using Caenorhabditis elegans drosophila melanogaster and galleria mellonella as model hosts for infectious disease research. Adv. Exp. Med. Biol. 710, 11-17 (2012).
76. Rendueles O, Ferrieres L, Fretaud M et al. A new zebrafish model of oro-intestinal pathogen colonization reveals a key role for adhesion in protection by probiotic bacteria. PLoS Pathog. 8(7), e1002815 (2012).
77. Panayidou S, Ioannidou E, Apidianakis Y. Human pathogenic bacteria, fungi, and viruses in drosophila: disease modeling, lessons, and shortcomings. Virulence 5(2), 253-269 (2014).
78. Mulcahy H, Sibley CD, Surette MG, Lewenza S. Drosophila melanogaster as an animal model for the study of Pseudomonas aeruginosa biofilm infections in vivo. PLoS Pathog. 7(10), e1002299 (2011).
79. Korgaonkar A, Trivedi U, Rumbaugh KP, Whiteley M. Community surveillance enhances Pseudomonas aeruginosa virulence during polymicrobial infection. Proc. Natl Acad. Sci. USA 110(3), 1059-1064 (2013).
80. Zhang R, Hou A. Host-microbe interactions in Caenorhabditis elegans. ISRN Microbiol 2013 356-451 (2013).
81. Jebamercy G, Balamurugan K. Effects of sequential infections of Caenorhabditis elegans with Staphylococcus aureus and Proteus mirabilis. Microbiol. Immunol. 56(12), 825-835 (2012).
82. Darby C, Hsu JW, Ghori N, Falkow S. Caenorhabditis elegans: plague bacteria biofilm blocks food intake. Nature 417(6886), 243-244 (2002).
83. Joshua GW, Karlyshev AV, Smith MP, Isherwood KE, Titball RW, Wren BW. A Caenorhabditis elegans model of yersinia infection: biofilm formation on a biotic surface. Microbiology 149(Pt 11), 3221-3229 (2003).
84. Begun J, Gaiani JM, Rohde H et al. Staphylococcal biofilm exopolysaccharide protects against Caenorhabditis elegans immune defenses. PLoS Pathog. 3(4), e57 (2007).
85. Vilela SF, Barbosa JO, Rossoni RD et al. Lactobacillus acidophilus atcc 4356 inhibits biofilm formation by C. albicans and attenuates the experimental candidiasis in Galleria mellonella. Virulence 6(1), 29-39 (2015).
86. Del Vecchio AM, Branigan PJ, Barnathan ES, Flavin SK, Silkoff PE, Turner RB. Utility of animal and in vivo experimental infection of humans with rhinoviruses in the development of therapeutic agents for viral exacerbations of asthma and chronic obstructive pulmonary disease. Pulm. Pharmacol. Ther. 30, 32-43 (2015).
87. Jhajharia K, Parolia A, Shetty KV, Mehta LK. Biofilm in endodontics: a review. J. Int. Soc. Prev. Community Dent. 5(1), 1-12 (2015).
88. Simon-Soro A, Guillen-Navarro M, Mira A. Metatranscriptomics reveals overall active bacterial composition in caries lesions. J. Oral Microbiol. 6, 25443 (2014).
89. Graves DT, Kang J, Andriankaja O, Wada K, Rossa C Jr. Animal models to study host-bacteria interactions involved in periodontitis. Front. Oral. Biol. 15, 117-132 (2012).
90. Kesavalu L, Sathishkumar S, Bakthavatchalu V et al. Rat model of polymicrobial infection, immunity, and alveolar bone resorption in periodontal disease. Infect. Immun. 75(4), 1704-1712 (2007).
91. Settem RP, El-Hassan AT, Honma K, Stafford GP, Sharma A. Fusobacterium nucleatum and Tannerella forsythia induce synergistic alveolar bone loss in a mouse periodontitis model. Infect. Immun. 80(7), 2436-2443 (2012).
92. Falsetta ML, Klein MI, Colonne PM et al. Symbiotic relationship between Streptococcus mutans and Candida albicans synergizes virulence of plaque biofilms in vivo. Infect. Immun. 82(5), 1968-1981 (2014).
93. Qureishi A, Lee Y, Belfield K, Birchall JP, Daniel M. Update on otitis media-prevention and treatment. Infect. Drug Resist. 7, 15-24 (2014).
94. Thornton RB, Rigby PJ, Wiertsema SP et al. Multi-species bacterial biofilm and intracellular infection in otitis media. BMC Pediatr. 11, 94 (2011).
95. Giebink GS. Otitis media: the chinchilla model. Microb. Drug Resist. 5(1), 57-72 (1999).
96. Bakaletz LO. Chinchilla as a robust, reproducible and polymicrobial model of otitis media and its prevention. Expert Rev. Vaccines 8(8), 1063-1082 (2009).
97. Clark JM, Brinson G, Newman MK et al. An animal model for the study of genetic predisposition in the pathogenesis of middle ear inflammation. Laryngoscope 110(9), 1511-1515 (2000).
98. Macarthur CJ, Trune DR. Mouse models of otitis media. Curr. Opin. Otolaryngol. Head Neck Surg. 14(5), 341-346 (2006).
99. Trune DR, Zheng QY. Mouse models for human otitis media. Brain Res. 1277, 90-103 (2009).
100. Tyrer HE, Crompton M, Bhutta MF. What have we learned from murine models of otitis media Curr. Allergy Asthma Rep. 13(5), 501-511 (2013).
101. Tikhomirova A, Kidd SP. Haemophilus influenzae and Streptococcus pneumoniae: living together in a biofilm. Pathog. Dis. 69(2), 114-126 (2013).
102. Weimer KE, Armbruster CE, Juneau RA, Hong W, Pang B, Swords WE. Coinfection with Haemophilus influenzae promotes pneumococcal biofilm formation during experimental otitis media and impedes the progression of pneumococcal disease. J. Infect. Dis. 202(7), 1068-1075 (2010).
103. Gitiban N, Jurcisek JA, Harris RH et al. Chinchilla and murine models of upper respiratory tract infections with respiratory syncytial virus. J. Virol. 79(10), 6035-6042 (2005).
104. Wren JT, Blevins LK, Pang B et al. Influenza a virus alters pneumococcal nasal colonization and middle ear infection independently of phase variation. Infect. Immun. 82(11), 4802-4812 (2014).
105. Bosch AA, Biesbroek G, Trzcinski K, Sanders EA, Bogaert D. Viral and bacterial interactions in the upper respiratory tract. PLoS Pathog. 9(1), e1003057 (2013).
106. Lopez Hernandez Y, Yero D, Pinos-Rodriguez JM, Gibert I. Animals devoid of pulmonary system as infection models in the study of lung bacterial pathogens. Front. Microbiol. 6, 38 (2015).
107. Huang YJ, Sethi S, Murphy T, Nariya S, Boushey HA, Lynch SV. Airway microbiome dynamics in exacerbations of chronic obstructive pulmonary disease. J. Clin. Microbiol. 52(8), 2813-2823 (2014).
108. Beasley V, Joshi PV, Singanayagam A, Molyneaux PL, Johnston SL, Mallia P. Lung microbiology and exacerbations in copd. Int. J. Chron. Obstruct. Pulmon. Dis. 7, 555-569 (2012).
109. Sherrard LJ, Tunney MM, Elborn JS. Antimicrobial resistance in the respiratory microbiota of people with cystic fibrosis. Lancet 384(9944), 703-713 (2014).
110. Baldan R, Cigana C, Testa F et al. Adaptation of Pseudomonas aeruginosa in cystic fibrosis airways influences virulence of Staphylococcus aureus in vitro and murine models of co-infection. PLoS ONE 9(3), e89614 (2014).
111. Bragonzi A, Farulla I, Paroni M et al. Modelling co-infection of the cystic fibrosis lung by Pseudomonas aeruginosa and Burkholderia cenocepacia reveals influences on biofilm formation and host response. PLoS ONE 7(12), e52330 (2012).
112. Seth AK, Geringer MR, Hong SJ, Leung KP, Mustoe TA, Galiano RD. In vivo modeling of biofilm-infected wounds: a review. J. Surg. Res. 178(1), 330-338 (2012).
113. Abdullahi A, Amini-Nik S, Jeschke MG. Animal models in burn research. Cell Mol. Life Sci. 71(17), 3241-3255 (2014).
114. Davidson JM, Yu F, Opalenik SR. Splinting strategies to overcome confounding wound contraction in experimental animal models. Adv. Wound Care (New Rochelle) 2(4), 142-148 (2013).
115. Dhall S, Do DC, Garcia M et al. Generating and reversing chronic wounds in diabetic mice by manipulating wound redox parameters. J. Diabetes Res. 2014, 562-625 (2014).
116. Zhao G, Usui ML, Underwood RA et al. Time course study of delayed wound healing in a biofilm-challenged diabetic mouse model. Wound Repair. Regen. 20(3), 342-352 (2012).
117. Seth AK, Geringer MR, Hong SJ, Leung KP, Galiano RD, Mustoe TA. Comparative analysis of single-species and polybacterial wound biofilms using a quantitative, in vivo rabbit ear model. PLoS ONE 7(8), e42897 (2012).
118. Roy S, Elgharably H, Sinha M et al. Mixed-species biofilm compromises wound healing by disrupting epidermal barrier function. J. Pathol. 233(4), 331-343 (2014).